ISOCHECKS
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

  • Home
  • Services
    • Validation Services
    • Implementation
    • Accreditation Services
    • Product Development
    • Training services
  • Further information
    • Regulation updates
    • Case Studies
    • Supporting information
    • About Us
  • More
    • Home
    • Services
      • Validation Services
      • Implementation
      • Accreditation Services
      • Product Development
      • Training services
    • Further information
      • Regulation updates
      • Case Studies
      • Supporting information
      • About Us
ISOCHECKS

Signed in as:

filler@godaddy.com

  • Home
  • Services
    • Validation Services
    • Implementation
    • Accreditation Services
    • Product Development
    • Training services
  • Further information
    • Regulation updates
    • Case Studies
    • Supporting information
    • About Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Business Case for Services

 The cost of validation is planned and controllable. The cost of inadequate validation is often unexpected, disruptive, and substantially higher." 

Cost of delay

What is it costing your laboratory every week that the service isn't live


  1. Staff time
  2. Referral testing
  3. Reagent/analyser under-utilisation
  4. Project management time
  5. Repeat validation work
  6. Delayed clinical pathway
  7. Delayed patient results
  8. Lost service capacity

  



 ISOCHECKS investment

    ↓

Faster, controlled implementation

     ↓

Earlier clinical service delivery

      ↓

Earlier return on laboratory investment

Get a free quote today

The Cost of Poor or Delayed Validation to Organisations

Cost incurred to correct mistakes to the health services

Cost incurred to correct mistakes to the health services
Cost incurred to correct mistakes to the health services

Failure to validate a diagnostic service properly can expose laboratories to significant financial, operational, regulatory, and clinical risks.

  

A robust validation programme typically costs a fraction of the expenses associated with remediation, regulatory findings, or delayed implementation.

Minor Compliance Gap

Cost incurred to correct mistakes to the health services
Cost incurred to correct mistakes to the health services

  1. Additional staff time to generate missing evidence
  2. Repeat  validation studies
  3. Documentation  updates
  4. Corrective  action plans
  5. UKAS  non-conformity response 

  

Typical Cost: £2,000 to £10,000

Delayed Service Implementation

Cost incurred to correct mistakes to the health services
Delayed Service Implementation

  1. Project delays
  2. Lost referral income
  3. Extended reagent evaluations
  4. Additional training requirements
  5. Delayed patient access to testing

  

Typical Cost: £10,000 to £50,000+

Major Validation Deficiency

Failed New Technology Implementation
Delayed Service Implementation

  1. Full revalidation of the service
  2. Consultant and specialist support
  3. Repeat method comparisons and statistical analysis
  4. Additional UKAS assessment activity
  5. Service  suspension or restricted accreditation scope

  

Typical Cost: £25,000 to £100,000+

Patient Safety Incident

Failed New Technology Implementation
Failed New Technology Implementation

  1. Investigation  costs
  2. Repeat patient testing
  3. Clinical review and governance processes
  4. Legal  and indemnity costs
  5. Reputational damage
  6. Service redevelopment 

  

Typical Cost: £50,000 to £500,000+

Failed New Technology Implementation

Failed New Technology Implementation
Failed New Technology Implementation

  1. Instrument      underutilization
  2. Wasted procurement investment
  3. Delayed commissioning
  4. Additional validation and verification work
  5. Loss  of business case benefits

 Typical Cost : £100,000 to £1M+ 

Validation Cost-Impact Matrix

This matrix can be used to help laboratories quantify the business risk associated with inadequate or delayed validation activities. 

ISO 15189 Compliance

 Medium Risk: Non-conformity requiring corrective action (£5k-15k).

 Severe Risk:  Loss of accreditation or suspended service (£50k+).

Staff Resource Impact

 Medium Risk: Repeat validation studies (£5k-20k) 

 Severe Risk: Dedicated recovery project (£50k+) 

Service Implementation Delay

 Medium Risk:  1-3 months (£10k-30k)  

 Severe Risk: Project failure or cancellation (£100k+) 

Revenue & Referrals

 Medium Risk: Loss of referrals (£25k-100k)   

 Severe Risk: Contract loss or service decommissioning (£100k+) 

Patient Safety Risk

 Medium Risk:  delay in diagnosis 

 Severe Risk:  Potential diagnostic error. Significant incident requiring investigation.


 If external specialist support gets your service live weeks earlier, the investment in validation can be small compared with the cost of delay.   

I need Express Implementation services

Challenges for Medical devices in clinical practice

Medical devices Regulations

Medical devices Regulations
Medical devices Regulations

 New In-Vitro Diagnostics Regulation(IVDR)  and ISO 15189, 2022 introduces new compliance challenges for manufacturers and testing laboratories using in-house devices 

Laboratory developed test

Medical devices Regulations
Medical devices Regulations

IVDR now makes concrete demands on laboratories using any laboratory developed test.  A lot of medical laboratories are not fully aware of the existing and the new requirements

Intended use deviation

Intended use deviation
Intended use deviation

With a rapidly changing world of therapeutics a lot of devices do not have 

 clinical performance studies or clinical testing to  correlate with the products stated 'intended use' provided with the IVD technical documentation    

Implementation delays

Intended use deviation
Intended use deviation

Verification process delays with Clinical laboratories trying to achieve ISO accreditation leaving new and better devices out of clinical use.

Pathology organizations adopting a multi-site hub and spoke model introduces new implementation challenges for laboratory management 

  • Regulation updates
  • Blog
  • Terms and Conditions
  • Privacy Policy
  • Modern Slavery Statement

ICS DIAGNOSTIC SOLUTIONS LIMITED

Company Number 16678742

ISOChecks.co.uk

Copyright © 2025 ISOChecks.co.uk - All Rights Reserved.

Powered by GoDaddy